Session Information
2013 Midyear Clinical Meeting
Click here to go to the previous page
Headline News: USP and NIOSH Guidance in the Face of Compounding Tragedy and Hazardous Drug Dangers
Track:
Education Sessions (CE)
Program Code: 346-L03
Date: Tuesday, December 10, 2013
Time: 9:30 AM to 11:00 AM EST
Location:
Valencia W415 C, Level 4
PRESENTER(S):
Mr. Eric Kastango, MBA, RPh, President/CEO, Clinical IQ, LLC
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
- Describe the risks of workplace exposure to hazardous drugs.
- Identify issues discussed by congressional hearings and pharmacy state boards on contaminated sterile preparations.
- List the areas of concern to the USP Expert Panel on Hazardous Drugs compounding.
- List the risks of failing to apply appropriate quality assurance to compounding or buying sterile preparations.
This session is a part of: